References
- Vasan RS. Biomarkers of cardiovascular disease, molecular basis and practical considerations. Circulation113, 2335–2362 (2006).
- de Roos B, McArdle HJ. Proteomics as a tool for the modelling of biological processes and biomarker development in nutrition research. Br. J. Nutr.99, S66–S71 (2008).
- de Roos B. Proteomic analysis of human plasma and blood cells in nutritional studies: development of biomarkers to aid disease prevention. Expert Rev. Proteomics5, 819–826 (2008).
- Service RF. Proteomics. Will biomarkers take off at last? Science321, 1760 (2008).
- Arbones-Mainar JM, Ross K, Rucklidge GJ et al. Extra virgin olive oils increase hepatic fat accumulation and hepatic antioxidant protein levels in APOE(-/-) mice. J. Proteome Res.6, 4041–4054 (2007).
- de Roos B, Rucklidge G, Reid M et al. Divergent mechanisms of cis9, trans11-and trans10, cis12-conjugated linoleic acid affecting insulin resistance and inflammation in apolipoprotein E knockout mice: a proteomics approach. FASEB J.19, 1746–1748 (2005).
- de Roos B, Duivenvoorden I, Rucklidge G et al. Response of apolipoprotein E*3-leiden transgenic mice to dietary fatty acids, combining liver proteomics with physiological data. FASEB J.19, 813–815 (2005).
- de Roos B, Duthie SJ, Polley AC et al. Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells. J. Proteome Res.7, 2280–2290 (2008).
- Service RF. Proteomics. Proteomics ponders prime time. Science321, 1758–1761 (2008).